Jacobs Growth Could Improve on Data Centers, Life Sciences Demand, RBC Says

MT Newswires Live
05/20

Jacobs (J) could see stronger growth in H2 as data center demand, Life Sciences work, US infrastructure spending, AI use and shareholder returns support the outlook, RBC Capital Markets said in a note Monday.

Jacobs' demand backdrop remains healthy, with Life Sciences and Advanced Facilities expected to improve further in H2, and the company is already seeing better growth, helped by higher net revenue in fiscal Q1 and fiscal Q2, the investment firm said.

RBC said about 10% of Jacobs' business is linked to the AI market, including data centers, power, energy and semiconductors, with demand supported by hyperscalers and neocloud companies, adding that Jacobs could win more work from Hut 8 (HUT) after securing a second AI data center project, helped by its growing relationship with the customer and its data center work with Nvidia (NVDA).

The US infrastructure outlook also remains supportive, with about half of the $500 billion IIJA funding allocated and a possible surface transportation reauthorization later this year, according to the note.

RBC kept the company's outperform rating and $169 price target.

Price: 114.11, Change: +0.50, Percent Change: +0.44

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10